Published on: May 30, 2018 at 12:00PM
Condition: Small-cell Lung Cancer
Intervention: Drug: Atezolizumab
Sponsors: Norwegian University of Science and Technology; University Hospital of North Norway; Alesund Hospital; Vestre Viken Hospital Trust; University Hospital, Akershus; Levanger Hospital; Helse Stavanger HF; The Hospital of Vestfold; Haukeland University Hospital; Sorlandet Hospital HF
Not yet recruiting
https://ift.tt/2xumS4B
No comments:
Post a Comment